Form 8-K - Current report:
SEC Accession No. 0000950170-25-074589
Filing Date
2025-05-19
Accepted
2025-05-19 17:22:45
Documents
10
Period of Report
2025-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K caba-20250515.htm   iXBRL 8-K 46141
  Complete submission text file 0000950170-25-074589.txt   152372

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20250515.xsd EX-101.SCH 24882
12 EXTRACTED XBRL INSTANCE DOCUMENT caba-20250515_htm.xml XML 4709
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 25965158
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)